News Quantified

SRNE – sorrento therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Top News Gainers

11/22 Form S-3 Sorrento Therapeutics, 93.2%

1/10 Sorrento Therapeutics, Inc. Received Non-Binding Acquisition Proposal 19.0%

6/17 Form 8-K Sorrento Therapeutics, For: Jun 17 15.6%

8/16 Sorrento Therapeutics Inc (NASDAQ: SRNE) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 8.2%

4/2 SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS 7.4%

11/6 Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences 7.0%

10/15 Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward 6.1%

4/9 Form SC 13G/A Sorrento Therapeutics, Filed by: BlackRock Inc. 5.4%

7/2 Sorrento Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Warrants 5.3%

5/13 Form 8-K Sorrento Therapeutics, For: May 13 5.0%

Top News Decliners

10/7 Sorrento Therapeutics Inc (NASDAQ: SRNE) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $21.00 price target on the stock. -31.0%

2/27 Form 8-K Sorrento Therapeutics, For: Feb 27 -26.1%

6/28 Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants -21.0%

1/10 Sorrento receives a near $1 billion takeout offer [Reuters] -13.9%

1/29 Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection -13.6%

1/11 Sorrento surges on a near $1 billion takeout offer [Yahoo! Finance News] -13.3%

1/27 Sorrento Board Rejects Latest Acquisition Proposal -13.2%

3/13 Form S-3 Sorrento Therapeutics, -11.8%

3/20 SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19) -10.9%

2/11 Form 8-K Sorrento Therapeutics, For: Feb 10 -10.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day